The University of Lausanne is offering this technology for licensing or for collaboration. The technology is a method for a new culture protocol that allows in vitro generation of human adult neural cell.

Development Phase :

validated cell culture protocol

Patent Status :

A provisional patent application has been filed in august 2001. Patent pending.

Patent Attorney :
Mintz & Levin, Boston, USA

Novelty and Benefits :
¨
Neural cells from human adult origin
¨ Highly efficient culture protocol
¨ Avoids xeno- and allo- graft inconveniences.

Human Brain Cell Culture Optimisation

(Reference Number IDF 21/01)

The Technology :

Both fundamental studies in neural cell biology and development of cell therapy strategies require the development of methods providing readily available human neural cells.

Several methods have been developed over the past years, essentially based on production of stem cells from f?tal or adult brain tissue or on the differentiation of stem cells from peripheral tissue such as bone marrow.

We propose an optimised culture protocol for adult human brain cells with remarkable cell production efficiency in primoculture.

Applications :

This technology should also be of great interest to any company active in the area of brain repair following neurodegenerative pathologies, mechanical brain damage repair, ex-vivo gene therapy, autograft.